Ken Griffin Biotechnology

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
AKBA
Akebia Therapeutics, Inc.
PUT
$167,000
89.8K
Q4 2024
New holding
ABUS
Arbutus Biopharma Corp
CALL
$164,000
50.4K
Q4 2024
Reduced 54.33%
COGT
Cogent Biosciences, Inc.
PUT
$164,000
21.1K
Q4 2024
Added 912.37%
VERU
Veru Inc.
CALL
$161,000
249K
Q4 2024
New holding
VIR
Vir Biotechnology, Inc.
CALL
$155,000
21.2K
Q4 2024
Added 0.85%
CABA
Cabaletta Bio, Inc.
PUT
$149,000
68K
Q3 2024
Reduced 98.59%
EDIT
Editas Medicine, Inc.
PUT
$148,000
117K
Q4 2024
Added 164.0%
TRDA
Entrada Therapeutics, Inc.
CALL
$148,000
8.6K
Q4 2024
Reduced 19.9%
DNLI
Denali Therapeutics Inc.
PUT
$138,000
6.8K
Q4 2024
Added 6.77%
IMUX
Immunic, Inc.
PUT
$136,000
136K
Q4 2024
Reduced 99.88%
SCPH
Sc Pharmaceuticals Inc.
CALL
$136,000
38.5K
Q3 2024
Reduced 28.48%
SGMO
Sangamo Therapeutics, Inc
CALL
$133,000
131K
Q4 2024
Added 10.63%
VYGR
Voyager Therapeutics, Inc.
PUT
$130,000
23K
Q4 2024
Reduced 98.56%
VTYX
Ventyx Biosciences, Inc.
PUT
$129,000
59.3K
Q4 2024
Added 0.59%
VERU
Veru Inc.
PUT
$128,000
198K
Q4 2024
New holding
XFOR
X4 Pharmaceuticals, Inc
CALL
$127,000
166K
Q2 2024
Reduced 98.9%
CHRS
Coherus Bio Sciences, Inc.
PUT
$126,000
91.8K
Q3 2024
Added 0.48%
OLMA
Olema Pharmaceuticals, Inc.
CALL
$125,000
21.5K
Q4 2024
Added 34.36%
TNYA
Tenaya Therapeutics, Inc.
PUT
$125,000
88.1K
Q4 2024
Reduced 81.21%
SWTX
Spring Works Therapeutics, Inc.
CALL
$122,000
3.4K
Q4 2024
Added 185.55%
PHAT
Phathom Pharmaceuticals, Inc.
CALL
$121,000
15K
Q4 2024
Reduced 67.33%
ALLO
Allogene Therapeutics, Inc.
CALL
$120,000
56.7K
Q4 2024
Added 6.14%
KMPH
Kempharm, Inc
PUT
$119,000
24.1K
Q4 2024
Reduced 96.33%
KURA
Kura Oncology, Inc.
CALL
$119,000
13.7K
Q4 2024
Reduced 16.99%
CNTA
Centessa Pharmaceuticals PLC
CALL
$117,000
7K
Q4 2024
Added 6.43%
LRMR
Larimar Therapeutics, Inc.
PUT
$117,000
30.8K
Q3 2024
Added 826.4%
LXRX
Lexicon Pharmaceuticals, Inc.
PUT
$116,000
157K
Q4 2024
Reduced 73.81%
IMNM
Immunome Inc.
PUT
$114,000
11.2K
Q4 2024
New holding
KALV
Kal Vista Pharmaceuticals, Inc.
CALL
$114,000
13.5K
Q4 2024
Added 7.26%
SANA
Sana Biotechnology, Inc.
CALL
$112,000
69.1K
Q4 2024
Added 572.38%
GOSS
Gossamer Bio, Inc.
CALL
$110,000
123K
Q4 2024
Reduced 86.54%
GLUE
Monte Rosa Therapeutics, Inc.
PUT
$110,000
15.9K
Q4 2024
Reduced 32.84%
MRVI
Maravai Lifesciences Holdings, Inc.
PUT
$109,000
20.1K
Q4 2024
New holding
SVRA
Savara Inc
CALL
$109,000
35.7K
Q4 2024
Reduced 45.16%
CRBU
Caribou Biosciences, Inc.
PUT
$107,000
67.4K
Q3 2024
Added 3.15%
MIRM
Mirum Pharmaceuticals, Inc.
CALL
$107,000
2.6K
Q4 2024
Added 8.61%
RVPH
Reviva Pharmaceuticals Holdings, Inc.
PUT
$107,000
62K
Q3 2024
New holding
TNYA
Tenaya Therapeutics, Inc.
CALL
$106,000
74.3K
Q4 2024
Reduced 81.21%
ABUS
Arbutus Biopharma Corp
PUT
$104,000
32.1K
Q4 2024
Reduced 54.33%
CVAC
Cure Vac N.V.
CALL
$104,000
30.6K
Q3 2024
Added 288.26%
URGN
Uro Gen Pharma Ltd.
PUT
$104,000
9.8K
Q4 2024
Reduced 5.49%
LRMR
Larimar Therapeutics, Inc.
CALL
$103,000
27.2K
Q3 2024
Added 826.4%
OCGN
Ocugen, Inc.
PUT
$99,000
124K
Q4 2024
New holding
SAGE
Sage Therapeutics, Inc.
PUT
$98,000
18.2K
Q4 2024
Reduced 86.16%
STOK
Stoke Therapeutics, Inc.
PUT
$98,000
8.9K
Q4 2024
Added 1232.09%
VTYX
Ventyx Biosciences, Inc.
CALL
$97,000
44.4K
Q4 2024
Added 0.59%
REPL
Replimune Group, Inc.
CALL
$96,000
8K
Q4 2024
Added 0.43%
XNCR
Xencor Inc
PUT
$96,000
4.2K
Q4 2024
Reduced 78.5%
GLPG
Galapagos Nv
CALL
$93,000
3.4K
Q4 2024
Reduced 14.84%
Filter Shares Options
Ken Griffin

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.
Track Ken Griffin's portfolio
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email